SOPH News | Roxom Stocks

Invest Private Security Newsroom

Market Overview

Indices and commodities.

Bitcoin treasury preferreds.

The artificial intelligence theme.

Bitcoin Treasuries

Companies holding bitcoin.

Sectors, global markets and rates.

Popular Portfolios

13F filings, smart money.

Borrow USDT or USDC against your BTC without giving it up.

Switch your bitcoin-backed loan and pay less interest.

Borrow, invest, keep the spread.

Stock Dividends

Dividends from tokenized equities.

Company

Our leadership team, mission, and investors.

Vision, purpose, and architecture behind Roxom.

Terms, privacy, and disclosures.

Resources

Guides, FAQs & support.

Trading logic, platform rules, and fundamentals.

Connect, authenticate, and build with our API.

Current platform health and incidents.

Loading chart

Pay with

1 BTC

=

- USD

Loading market data...

Loading chart

Pay with

SO

Mkt Cap

$574.4M

Volume

639.20K

Next Earnings

November 3rd

Loading chart

SO

SOPHSOPHiA GENETICS SA Ordinary Shares

SOPH

Pay with—

Available Balance0.00

SO

Mkt Cap

$572.9M

Volume

639.20K

Next Earnings

November 3rd

Chart Financials Earnings News About Insider Filings

AI Poised to Reshape Blood Cancer Therapeutics as Investment Surges Past $2 Billion Across Leading Biotech and Pharma PlayersArtificial intelligence is transforming blood cancer drug discovery and development, with over $2 billion in investment from major biotech and pharma companies. AI is reducing clinical trial timelines by up to 50%, improving patient selection, and enabling next-generation therapies like CAR-T and antibody-drug conjugates. North America leads with 40% of global market share, while Asia-Pacific emerges as a significant growth region.GlobeNewswire Inc. · Aug 25, 2026

Stock Market Today: Dow Futures Tumble, S&P 500, Nasdaq Gains As Investors Await FOMC Decision— Amkor, La-Z-Boy In Focus (UPDATED)U.S. stock futures showed mixed performance on Wednesday with the Dow Jones declining while the S&P 500 and Nasdaq 100 advanced. Investors awaited the FOMC interest rate decision expected at 2:00 p.m. ET, with markets pricing a 99.6% likelihood of unchanged rates. Notable movers included La-Z-Boy surging 19.62% on strong earnings and a $300 million buyback, Amkor jumping 5.49% after signing a 10-year deal with TSMC, and SpaceX rising 3.22% following its Cursor AI acquisition.Benzinga · Jun 17, 2026

Artificial Intelligence in Diagnostics Market to hit USD 7.3 billion by 2032, says Global Market Insights Inc.The artificial intelligence in diagnostics market is projected to grow at a CAGR of 22.2% from 2024 to 2032, driven by the rising prevalence of chronic diseases and the increasing demand for AI tools in disease diagnosis.GlobeNewswire Inc. · Oct 7, 2024

SOPHiA GENETICS Publishes Results of 2024 Annual General MeetingShareholders adopt all proposals at Annual General Meeting Shareholders adopt all proposals at Annual General MeetingGlobeNewswire Inc. · Jun 24, 2024

Why Nvidia Stock Investors Should Be Excited About an Upcoming IPOCoreWeave, a company backed by Nvidia, is preparing to go public in 2025.The Motley Fool · May 30, 2024

Wall Street Analysts Think SOPHiA GENETICS (SOPH) Could Surge 64.95%: Read This Before Placing a BetThe average of price targets set by Wall Street analysts indicates a potential upside of 65% in SOPHiA GENETICS (SOPH). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.Zacks Investment Research · May 7, 2024

SOPHiA GENETICS Reports First Quarter 2024 ResultsConsistent Operational Execution; Robust New Business Momentum; Guidance Reaffirmed Consistent Operational Execution; Robust New Business Momentum; Guidance ReaffirmedGlobeNewswire Inc. · May 7, 2024

SOPHiA GENETICS to Present at the 2024 RBC Capital Markets Global Healthcare ConferenceBOSTON and ROLLE, Switzerland, April 30, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS, a cloud-native software company and a leader in data-driven medicine, today announced that Chief Financial Officer and Chief Operating Officer, Ross Muken, will present at the 2024 RBC Capital Markets Global Healthcare Conference in New York City on Tuesday, May 14, 2024, at 3:35 p.m. EDT.GlobeNewswire Inc. · Apr 30, 2024

SOPHiA GENETICS to Announce Financial Results for First Quarter 2024 on May 7, 2024BOSTON and ROLLE, Switzerland, April 23, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS, a cloud-native software company and a leader in data-driven medicine, today announced it will release its financial results for the first quarter of fiscal year 2024 before U.S. markets open on Tuesday, May 7, 2024. On that day, SOPHiA GENETICS will host a conference call to discuss its financial results as well as business outlook beginning at 8:00 a.m. (08:00) EDT / 2:00 p.m. (14:00) CET.GlobeNewswire Inc. · Apr 23, 2024

SOPHiA GENETICS to Present at the Barclays 26th Annual Global Healthcare ConferenceBOSTON and ROLLE, Switzerland, March 07, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced Chief Financial Officer and Chief Operating Officer, Ross Muken, will participate in a fireside chat at the Barclays 26th Annual Global Healthcare Conference on Wednesday, March 13, 2024, at 2:35 p.m. EDT.GlobeNewswire Inc. · Mar 7, 2024

to start trading

SO

SOPHSOPHiA GENETICS SA Ordinary Shares

SOPH

Pay with—

Available Balance0.00

Your PositionYou don't own any SOPH yet.

Related Tickers

Earnings